Oligonucleotide compositions and their use for the modulation of immune responses

Details for Australian Patent Application No. 2003219383 (hide)

Owner Bioniche Life Sciences Inc.

Inventors Phillips, Nigel, C.; Filion, Mario, C.

Agent FB Rice

Pub. Number AU-B-2003219383

PCT Number PCT/IB03/01488

PCT Pub. Number WO2003/089642

Priority 60/374,540 22.04.02 US

Filing date 22 April 2003

Wipo publication date 3 November 2003

Acceptance publication date 26 August 2010

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/70 (2006.01) - Carbohydrates

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/374,540 22.04.02 US

11 December 2003 Application Open to Public Inspection

  Published as AU-B-2003219383

26 August 2010 Application Accepted

  Published as AU-B-2003219383

23 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219384-A SYSTEM AND METHOD FOR CONNECTING MULTICAST OR BROADCAST CONTROL INFORMATION TO MOBILE STATIONS

2003219382-ELECTROLUMINESCENT PANEL